Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

Waters Corporation (WAT) — XLV Health Care · S&P 500 Profile |沃特斯公司介紹

health-careS&P500xlv
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

Waters Corporation (WAT) — Business, History & S&P 500 Profile |沃特斯公司介紹

Waters company profile · liquid chromatography, mass spectrometry & lab instruments · history · financial snapshot · S&P 500 rank #251 · 沃特斯公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Nov 2, 2026
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$45.46B
Nov 2, 2026 · StockAnalysis
S&P 500 WEIGHT
0.07%
Rank #251 · Nov 2, 2026 (Slickcharts)
FY2025 TOTAL NET SALES
$3,165.3M
+7.0% YoY
FY2025 NET INCOME
$642.6M
Diluted EPS $10.76

SNAPSHOT

TickerWAT (NYSE)
CompanyWaters Corporation
GICS sector / industryHealth Care (XLV) / Life Sciences Tools & Services
S&P 500 rank (by weight)#251 · 0.07% (Nov 2, 2026)
Sector rank (by S&P 500 weight)#32 in Health Care (Nov 2, 2026)
HeadquartersMilford, Massachusetts
Founded1958, in Milford, Massachusetts
CEOUdit Batra (president and CEO since Sep 1, 2020)
Market cap$45.46B (Nov 2, 2026)
SEC filingsEDGAR — CIK 0001000697

WHAT IT DOES

Waters makes analytical instruments and software used to measure what is in a sample: liquid chromatography, mass spectrometry and related consumables and services for pharmaceutical, food, environmental and materials laboratories.

Pharmaceutical customers are the largest buyer class, followed by industrial accounts and academic and government labs. The business is a classic razor-and-blade model: instruments placed in labs generate recurring consumables and service revenue.

FY2025 total net sales rose 7.0% to $3,165.3M, operating income was $802.6M and net income was $642.6M, with diluted EPS of $10.76. In 2025, sales grew 10% in both China and Europe and 3% in the United States. FY2025 interest expense includes about $16M of financing costs incurred on behalf of SpinCo in connection with the BDS Business Acquisition financing.

SALES BY CUSTOMER CLASS — FY2025

SegmentNet salesShareYoY
Pharmaceutical$1,873.4M59.2%—
Industrial$961.2M30.4%—
Academic & Government$330.7M10.4%—
Sales are split by customer class as disclosed in the 10-K, not by product segment. YoY shown as — where the 10-K passages do not state a comparable prior-year segment figure; no figure is estimated.

HISTORY

YearMilestone
1958Waters founded in Massachusetts.
1995Initial public offering on the New York Stock Exchange.
2023Acquires Wyatt Technology, adding light-scattering instruments.
2025FY2025 net sales $3,165.3M, up 7.0%, with growth in China and Europe.

COMPETITIVE POSITION

  • Against Danaher (Cytiva, SCIEX), Agilent and Thermo Fisher in chromatography and mass spectrometry.
  • Against Shimadzu and Bruker in instruments, and PerkinElmer in applied markets.
  • Consumables and service attach rates decide the installed-base economics.
  • Pharma capital spending and China demand are the swing factors for growth.

FINANCIAL SNAPSHOT — FY2025

Total net sales$3,165.3M (+7.0% YoY, vs $2,958.4M)
Operating income$802.6M
Net income$642.6M
Diluted EPS$10.76
FY2025 = year ended Dec 31, 2025, per Waters Form 10-K filed Feb 23, 2026. Employee count is omitted: it was not verified from the 10-K text.

KEY RISKS

  • Pharma and biotech capital-spending cycles.
  • China exposure: policy, pricing and local-competition risk.
  • Instrument competition and pricing pressure from larger diversified rivals.
  • Currency translation on a majority-non-US revenue base.

WHY IT MATTERS FOR THE S&P 500

Waters is the analytical-instrument pure play in the index: its order trends read directly on pharmaceutical R&D and quality-control spending.

At S&P 500 rank #251 with a 0.07% weight, it represents life sciences tools and services inside Health Care.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price — Nov 2, 2026 crawl) · StockAnalysis (market cap — Nov 2, 2026 crawl, single source)
FinancialsWaters Form 10-K FY2025 (filed Feb 23, 2026), consolidated statements and customer-class split
Sector classificationGICS via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

WATERS

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

股票代號WAT(NYSE)
公司Waters Corporation
GICS 板塊/行業健康護理(XLV)/Life Sciences Tools & Services
標普500排名(按權重)第251名 · 0.07%(2026 年 11 月 2 日)
板塊內排名(按標普500權重)健康護理第32名(2026 年 11 月 2 日)
總部麻省米爾福德
成立1958年,麻省米爾福德
行政總裁Udit Batra(總裁兼行政總裁,2020年9月1日起)
市值$45.46B(2026 年 11 月 2 日)
SEC 文件EDGAR — CIK 0001000697

業務概覽

沃特斯生產用於檢測樣本成分的分析儀器與軟件:液相色譜、質譜及相關耗材與服務,服務製藥、食品、環境與材料實驗室。

製藥客戶為最大買家類別,其次為工業客戶與學術及政府實驗室。業務屬典型「剃刀與刀片」模式:裝機儀器帶來經常性耗材與服務收入。

FY2025 總淨銷售額增長 7.0% 至 31.653 億美元,營運利潤 8.026 億美元,淨利潤 6.426 億美元,攤薄每股收益 10.76 美元。2025 年中國與歐洲銷售各增長 10%,美國增長 3%。FY2025 利息開支包含約 1,600 萬美元為 SpinCo 就 BDS 業務收購融資承擔的融資成本。

按客戶類別劃分的銷售額 — FY2025

板塊淨銷售額佔比同比
製藥$1,873.4M59.2%—
工業$961.2M30.4%—
學術與政府$330.7M10.4%—
銷售額按 10-K 披露的客戶類別劃分,而非按產品板塊。同比以 — 表示者,為10-K 段落未披露可比上年板塊數字之處;不作估算。

歷史沿革

年份里程碑
1958沃特斯於麻省成立。
1995紐約證券交易所首次公開招股。
2023收購 Wyatt Technology,增加光散射儀器。
2025FY2025 淨銷售額 31.653 億美元,同比增長 7.0%,中國與歐洲均增長。

競爭地位

  • 色譜與質譜方面對手為丹納赫(Cytiva、SCIEX)、安捷倫與賽默飛。
  • 儀器方面對手為島津與布魯克,應用市場對手為珀金埃爾默。
  • 耗材與服務附著率決定裝機基礎的經濟效益。
  • 製藥資本開支與中國需求為增長的關鍵變量。

財務快照 — FY2025

總淨銷售額$3,165.3M(同比 +7.0%,上年 $2,958.4M)
營運利潤$802.6M
淨利潤$642.6M
攤薄每股收益$10.76
FY2025 為截至 2025 年 12 月 31 日止年度,據沃特斯 10-K(2026 年 2 月 23 日提交)。員工數從略:10-K 文本未核實該數字。

主要風險

  • 製藥與生物科技資本開支周期。
  • 中國敞口:政策、定價與本地競爭風險。
  • 來自大型多元化對手在儀器方面的競爭與定價壓力。
  • 多數收入來自美國以外,面臨匯率折算風險。

對標普500的重要性

沃特斯是指數中的分析儀器純粹代表:其訂單趨勢直接反映製藥研發與質量控制開支。

標普500排名第251位、權重 0.07%,代表健康護理板塊內的生命科學工具與服務行業。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格——2026 年 11 月 2 日抓取)· StockAnalysis(市值——2026 年 11 月 2 日抓取,單一來源)
財務沃特斯 FY2025 10-K(2026 年 2 月 23 日提交),合併報表與客戶類別劃分
板塊分類GICS,據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

WATERS

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · WAT
Data as of Nov 2, 2026 · Financials FY2025 (10-K) · Market data Nov 2026
Previous · MSCI Inc. (MSCI) — XLF Financials · S&P 500 Profile |明晟公司介紹Next · Ciena Corporation (CIEN) — XLK Information Technology · S&P 500 Profile |西耶那公司介紹

Entered 2026-11-01 20:08 · updated 2026-11-15 00:16 · rev 5